American Society of Hematology

Fig. 1.

$Fig. 1. FTOC assessment of progenitor function in HIV+ patients. / (A) CD4+, CD8+, and CD4+/CD8+ (DP) cell development in FTOC from peripheral blood of HIV+ patients. Samples were split; half were CD34+ cell enriched (▪), and the other half were used unfractionated (□). (B) Kinetics of development in FTOC from unfractionated PBMC of HIV− and HIV+participants. Immature cells were CD4+/CD3− (▪), mature cells (•) were CD3+/CD4+ or CD8+ cells (▴) represents double positive cells. Graphs show mean ± SEM of cells from 3 different donors.$

FTOC assessment of progenitor function in HIV⁺ patients.

(A) CD4⁺, CD8⁺, and CD4⁺/CD8⁺ (DP) cell development in FTOC from peripheral blood of HIV⁺ patients. Samples were split; half were CD34⁺ cell enriched (▪), and the other half were used unfractionated (□). (B) Kinetics of development in FTOC from unfractionated PBMC of HIV⁻ and HIV⁺participants. Immature cells were CD4⁺/CD3⁻ (▪), mature cells (•) were CD3⁺/CD4⁺ or CD8⁺ cells (▴) represents double positive cells. Graphs show mean ± SEM of cells from 3 different donors.

This Feature Is Available To Subscribers Only